Insider · CIK 0001998173

Christine Fox

officer

Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). First filing Nov 21, 2024, latest Mar 6, 2025.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

0 / 2

$0 bought, $425k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TEVA: TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVAOct 9, 2026 · close 41.10

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
5Weak	TEVAsell 510b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	$98k 6,181 shares	-10%	-	Mar 6, 2025
5Weak	TEVAsell10b5-1 TEVA PHARMACEUTICAL INDUSTRIES LTD	$327k 19,388 shares	-31%	-	Nov 21, 2024

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Mar 5, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	AGrant or award Restricted Share Unitsderivative	+71,278	$0.00	$0	71,278	Mar 7, 2025
Mar 4, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	MOption exercise Ordinary Shares10b5-1	+20,461	-	-	64,565	Mar 6, 2025
Mar 4, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SOpen-market sale Ordinary Shares10b5-1	-4,034	$15.73	$63k	60,531	Mar 6, 2025
Mar 5, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SOpen-market sale Ordinary Shares10b5-1	-2,147	$15.91	$34k	58,384	Mar 6, 2025
Mar 4, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	MOption exercise Restricted Share Unitsderivative10b5-1	-20,461	$0.00	$0	61,384	Mar 6, 2025
Nov 20, 2024	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	MOption exercise Ordinary Shares10b5-1	+63,492	-	-	63,492	Nov 21, 2024
Nov 20, 2024	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SOpen-market sale Ordinary Shares10b5-1	-19,388	$16.87	$327k	44,104	Nov 21, 2024
Nov 20, 2024	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	MOption exercise Restricted Share Unitsderivative10b5-1	-63,492	$0.00	$0	190,476	Nov 21, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.